|
The 14th International Pharma & Med Device Ethics & Compliance Congress Agenda-at-a-Glance Now Available
|
- Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
- Media Partners: Policy & Medicine Compliance Update and Rx Data News
- April 20 - 22, 2020
- Onsite at the Sheraton Munich Arabellapark Hotel
- Munich, Germany
- www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com |
AGENDA NOW AVAILABLE
|
Click here to view the conference agenda.
|
FEATURING KEYNOTE ADDRESS
ON TRUST IN BUSINESS BY
|
|
Roxana Family, Thèse de Doctorat Droit, Vice-President, Chair in Law & Business Ethics and Program Director, Cergy Pontoise University, Cergy-Pontoise, France |
|
AGENDA-AT-A-GLANCE
|
Monday, April 20, 2020
|
- Morning Preconferences:
- Closed-Door, Invitation-Only Chief Compliance Officer Roundtable
- ETHICS Workshop on Practical Ethics & Compliance Case Studies
|
- Afternoon Opening Plenary Session:
- Congress Welcome, Vision and Overview
- Keynote Address: Ethics, Compliance and the C-Suite
- International Anti-Corruption Landscape
- Senior Ethics & Compliance Professionals Roundtable
|
Tuesday, April 21, 2020
|
- Morning Plenary Session:
- Embedding Ethics in a Company Governance Model
- Global Compliance Codes Update
- Mini Summits:
- I Compliance Considerations for Small to Mid-Sized Organizations
- II Annual Medical Device Compliance Roundtable
- III Interconnectivity of Auditing, Monitoring, and Investigations
- IV Annual Central and Eastern Europe (CEE) Compliance Update
- V Best Practices for Compliance Training
- VI How to Build and Manage Compliance Risk Assessments
- VII Handling Ethics & Compliance When Interacting with 3rd Parties
- VIII EU Whistleblower Directive
|
- Mini Summits, Continued:
- IX Performing a Fair Market Value (FMV) Analysis
- X Compliance Considerations for Gene Therapy& Rare Disease Products
- XI GDPR and the Tumultuous World of Data Privacy
- XII Patient Relationships, Including Patient Access and Support
- XIII Enhanced Compliance Monitoring
- XIV Building Effective and Right Sized Compliance Programs
- XV Role of Compliance Officers in Complex Global Organizations
- Afternoon Plenary Session:
- Value-Based Proposition
- Ethical Interactions between Health Care & Other Stakeholders
- Ethics and New Technologies
|
Wednesday, April 22, 2020
|
- Mini Summits:
- XVI Annual Middle East Africa (MEA) Compliance Update
- XVII The Role of the Industry re: Medical Education
- XVII The Practical Effect on Implications of Brexit
|
- Closing Plenary Session:
- Drivers for a Sustainable Ethical Culture
- Trust in Business
- The Role of Governance
- Co-chairs Closing Thoughts
|
|
MUNICH, GERMANY -- PHARMA UPDATE NEWS SERVICE -- JANUARY 21, 2020: The Fourteenth International Pharmaceutical and Medical Device Ethics and Compliance Congress, www.InternationalPharmaCongress.com, will be held April 20 - 22, 2020 at the Sheraton Munich Arabellapark Hotel in Munich, Germany.
|
KEYNOTE SPEAKERS
|
Gemma Aiolfi
Head of Compliance, Corporate Governance and Collective Action, Basel Institute on Governance, Former Advisor, Working Group on Bribery in International Business Transactions, Organisation for Economic Co-operation and Development (OECD), Basel, Switzerland |
Julie Bonhomme
EFPIA Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium |
Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan, Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC, USA
|
Roxana Family, Thèse de Doctorat Droit
Vice-President, Chair in Law & Business Ethics and Program Director, Cergy Pontoise University, Cergy-Pontoise, France |
Susanne Friedrich, MA
Director, Group Governance, Human, Rights Division Global Policy, Governance, Alliance for Integrity (AfIn), Bonn, Germany |
Iordanis Kerenidis, PhD
Director, Paris Centre for Quantum Computing (PCQC), CNRS Senior Researcher (DR2), Algorithms and Complexity Group, IRIF, University Paris Diderot, Paris, France
|
Aline Lautenberg
General Counsel and Director, Legal & Compliance, MedTech Europe, Brussels, Belgium |
Sofie Melis
Head of Ethics and Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland
|
Hannes Oswald-Brugel, LLM, PhD
Global Head Pharma Healthcare Compliance, Roche, Vice President, Association of Voluntary Self-Regulation, for the Pharmaceutical Industry ("FSA"), Basel, Switzerland |
Christoph Thalheim
Vice CEO and Director External Affairs, European Multiple Sclerosis Platform (EMSP), Brussels, Belgium
|
|
|
FEATURING INVITATION-ONLY: CHIEF COMPLIANCE OFFICER ROUNDTABLE
|
(Special April 20 Morning Invitation-only, Closed Session)
SPONSORED BY
|
CO-SPONSORED BY
|
|
FEATURED FACULTY
|
Pablo Rojas Abad, LLM
Manager, Legal and Compliance, MedTech Europe, Brussels, Belgium |
Bas Amesz
Partner, Vintura, Baarn, Utrecht, Netherlands |
Natalie Ammerlaan, LLM
Compliance Director International Operations, Novo Nordisk, Zürich, Switzerland
|
Michael Bartke, PhD
Member, Strategic Committee, ETHICS, Former Director Ethics & Compliance, Alexion, Former Director Compliance Management, Daiichi Sankyo Europe, Munich, Germany |
Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Former Co-chair, International Pharmaceutical and Medical Device Compliance Congress, Paris, France |
Enno Behrendt
Associate Director, Guidehouse; Former Head of Compliance for Diagnostic Imaging, Siemens Healthcare GmbH; Berlin, Germany
|
Sadek Beloucif, MD
University Professor, Hospital Practitioner and Head of Anesthesia-Resuscitation, University of Paris and University Hospital, Bobigny, Chair, National Union of Physicians, Surgeons, Specialists, and Biologists of Public Hospitals, Paris, France |
Duygu Beyazo
Senior Associate, NSN Law Firm, Former Compliance Manager (Secondment), Business Conduct, Gilead Sciences, Istanbul, Turkey |
Stefano Biondi, LLB, PhD
Group Data Protection Officer, Menarini Group, Florence, Italy
|
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Raleigh-Durham, NC, USA |
Keith Burn
Global Investigations Director, Ipsen, Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS, Former Detective Constable, London Metropolitan Police, Amersham, Slough, UK |
Alice Choy, MS
Manager, Anti Bribery Anti-Corruption (ABAC), Compliance, Internal Audit, Risk Assessment, IQVIA, Former Lead Specialist, Transparency and Reporting, Johnson & Johnson, London, UK
|
Thomas Costa, JD
Member, US Board of Directors, Sanofi, Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC |
Holger Diener
Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry ("FSA"), Member, Ethics and Compliance Committee and Vice Chair, Code Committee, EFPIA, Member, IFPMA Code Compliance Network, Berlin, Germany |
Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany
|
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK |
Karen Eryou
Head, Ethics & Compliance Programs, Global, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium |
J. Mark Farrar, MSJ, CPA, CFE, CFF
Partner, Life Sciences Governance, Risk Management and Compliance, Guidehouse, Atlanta, GA
|
George Fife
Partner, Forensic & Integrity Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA |
Laura Coll Gil, LLM
Ethics and Compliance Officer, Boehringer Spain, Barcelona, Catalonia, Spain
|
Betania Glorio, LLM
Global Compliance Officer, Healthcare, Merck KGaA, Former Senior Director, Legal and Compliance EMEA, Horizon Pharma plc and Raptor Pharmaceuticals, Darmstadt, Germany |
Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, GA, USA |
Ulf H. Grundmann
Partner, FDA and Life Sciences, King & Spalding LLP, Lecturer, Frankfurt School of Finance and Management, Frankfurt am Main, Germany
|
Joseph W. Henein, PharmD
President and Chief Executive Officer, NewBridge Pharmaceuticals, Dubai, UAE |
Franziska Janorschke
Global Head, Business Practices Office, Novartis International AG, Basel, Switzerland |
Els Janssens, LLM
Associate, Baker & McKenzie, Former Legal Adviser, European Medicines Agency, Former Senior Legal Counsel, Johnson & Johnson, Brussels, Belgium
|
Anita Kyung-Hee Kim-Reinartz
Partner, Forensic & Integrity Services, EY, Düsseldorf, Germany |
Elisabeth Kohoutek
Senior Associate, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany |
Adem Koyuncu, MD, PhD (Law)
Partner and Chair, Food, Drug & Device Practice Group, Covington, Brussels, Belgium
|
Tomasz Kruk, LLM, MBA
Head of Compliance, Vifor Pharma, Former Director International Compliance, Mallinckrodt, Former Director Global Ethics & Compliance, Actavis, Zürich, Switzerland |
Edoardo Lazzarini, PhD
Healthcare Compliance Consultant, Former EuCan Ethics & Compliance Initiatives Director, Takeda Pharmaceuticals, Former Compliance Officer EMEA (Europe, Middle East & Africa), Zimmer Biomet, Milan, Italy |
Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China, Beijing, China
|
Marcel Maderitsch, LLM
Senior Compliance Officer, Vifor Pharma, Former Compliance Manager EMEA, Zimmer Biomet, Zurich, Switzerland |
Rosa Magistri, Esq., CIPP/E
Head of Legal and Compliance Europe, SeaGen International GmbH; Former Regional Director Office of Ethics and Compliance, Western Europe & Canada, Region South & Israel, AbbVie; Former Associate Compliance Director, Shire; Zug, Switzerland |
Anthony McQuillan, LLB
Vice President Legal & Compliance EMEA, Medtronic International, Former Senior Attorney EMEA, Hewlett-Packard, London, UK
|
Paul J. Melling, JD
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia |
Véronique Monjardet, MS, DEA, PhD
Sales Director, IQVIA, Paris, France |
Laura Nassar, PharmD
Vice President, Head of Ethics & Business Integrity, AEME Region, Sanofi, Chair, Compliance Committee, Pharmaceutical Research, and Manufacturers Association, Gulf (PhRMAG), Former Head of Compliance Middle East, Roche Pharmaceuticals, Beirut, Lebanon
|
Lauri G. Opar
Director, Risk Analytics, Global Ethics & Compliance, Glaxosmithkline, Brentford, Middlesex, UK |
Pascale Paimbault
President, CEO and Founder, Consulting Alley, Treasurer and Strategic Committee Member, ETHICS, Former Compliance Officer, France -Benelux, Biogen, Former Chief Compliance Officer EMEA, Wright Medical Inc., Former Senior Director, EMEA, Bristol-Myers Squibb, Paris, France |
Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo, Former Compliance Director Western Europe & Canada, AbbVie, Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France
|
Mario Prohasky
Global Compliance Consultant, IQVIA, London, UK |
Ariadna Quesada, MSJ
Law, Ethics and Compliance Officer, The Netherlands, AbbVie, Former Compliance Manager International, MicroPort Orthopedics, Amsterdam, Netherlands |
Nadège Rochel
Global Compliance Manager, Hollister Incorporated, Milan, Italy
|
Christian-Claus Roth
Head Scientific Engagement Governance, Novartis, Basel, Switzerland |
Giuseppe Saporito, LLM
Global Legal & Regulatory Expert, IQVIA, Milan, Italy |
Pascale Schmidt
Chief Compliance Officer, F. Hoffmann-La Roche Ltd, Basel, Switzerland
|
Leonardo Silva, LLM
Vice President, Global Chief Compliance & Privacy Officer, Ferring, Former Head of Compliance, Acino Group, Former Compliance Director, Emerging Markets, Takeda, Lausanne, Switzerland |
Tamara Tubin
International Compliance Director, Corporate Compliance, Wright Medical Group N.V., Vice Chair, Ethics & Compliance Committee, MedTech Europe, Member, Strategic Committee, ETHICS, Zürich, Switzerland |
Cláudia Vaz
Global Value Based HealthCare Consultant, Roche, Value-Based Health Care Consultant, International Consortium for Health, Outcomes Measurement (ICHOM), Basel, Switzerland
|
Vanessa Westphal, JD, LLM
Head of Compliance Programs & Support, Merck KGaA, Frankfurt am Main Area, Germany |
Christopher L. White, JD
Chief Operating Officer and General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA |
Mariusz Witalis
Partner, Forensic & Integrity Services, EY, Warsaw, Poland
|
Niels Wohlwend, LLM
Senior Director Healthcare Compliance, Europe & Canada, Celgene, Member, Ethics & Compliance Committee, EFPIA, Former Global Head of Compliance, ACINO, Boudry, Switzerland |
Elisabethann Wright, LLB
Partner, Hogan Lovells, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
|
|
|
2020 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
April 20 - 22, 2020
Sheraton Munich Arabellapark Hotel
Munich, Germany
www.International PharmaCongress.com
|
|
TWENTY-FIRST ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
November 4 - 6, 2020
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
SPONSORED BY:
|
|
CO CHAIRS
|
Anne-Sophie Bricca, MA, DEA International Law, DES European law
Deputy General Counsel & Senior Director Legal Affairs & Compliance, Terumo BCT, Chair, Ethics and Compliance Group and seats at the Code Committee, MedTech Europe, Brussels Area, Belgium
Stephen Nguyen Duc
Vice-President, Global Head of Human Resources and Ethics & Compliance, Medday Pharmaceuticals; Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Dominique Laymand, Esq.
Executive Vice President, Ethics & Social Responsibility, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Roeland Van Aelst
EMEA Lead Third Party Intermediary Ethics and Compliance, Johnson & Johnson, Chairman, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Europe Code Committee, Brussels, Belgium
|
GRANTORS
|
SILVER
|
|
BRONZE
|
|
MEDIA PARTNER:
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
INTERNATIONAL PHARMA CONGRESS IS
|
|
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - Shanghai
2012 - São Paulo
2013 - Madrid
2013 - Kuala Lumpur
2014 - Dubai
2014 - Mexico City
2014 - Shanghai
2015 - Manila
2016 - Warsaw
2017 - Lisbon
2018 - Vienna
2019 - Athens
|
|
|
|
|